Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Trial (management) and error.

Farrell B.

Lancet. 2019 May 11;393(10184):1935-1936. doi: 10.1016/S0140-6736(19)30029-7. No abstract available.

PMID:
31084964
2.

Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.

Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin PJ, Chenoweth L, Gorman M, Quirke L, Bethune G, Hilmer SN.

Med J Aust. 2019 Mar;210(4):174-179. doi: 10.5694/mja2.50015. Epub 2019 Feb 16.

PMID:
30771226
3.

Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people's lives in the context of health care trends, evidence and policies.

Dolovich L, Austin Z, Waite N, Chang F, Farrell B, Grindrod K, Houle S, McCarthy L, MacCallum L, Sproule B.

Can Pharm J (Ott). 2018 Dec 25;152(1):45-53. doi: 10.1177/1715163518815717. eCollection 2019 Jan-Feb. No abstract available.

4.

Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid.

Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre LM.

Can Pharm J (Ott). 2018 Dec 17;152(1):18-22. doi: 10.1177/1715163518816719. eCollection 2019 Jan-Feb. No abstract available.

5.

Deprescribing Is an Essential Part of Good Prescribing.

Farrell B, Mangin D.

Am Fam Physician. 2019 Jan 1;99(1):7-9. No abstract available.

PMID:
30600973
6.

Health care providers' roles and responsibilities in management of polypharmacy: Results of a modified Delphi.

Farrell B, Thompson W, Black CD, Archibald D, Raman-Wilms L, Grassau P, Patel T, Weaver L, Eid K, Winslade N.

Can Pharm J (Ott). 2018 Oct 11;151(6):395-407. doi: 10.1177/1715163518804276. eCollection 2018 Nov-Dec.

7.

Deprescribing conversations: a closer look at prescriber-patient communication.

Turner JP, Richard C, Lussier MT, Lavoie ME, Farrell B, Roberge D, Tannenbaum C.

Ther Adv Drug Saf. 2018 Oct 20;9(12):687-698. doi: 10.1177/2042098618804490. eCollection 2018 Dec.

8.

Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines.

Lee JY, Farrell B, Holbrook AM.

Pol Arch Intern Med. 2019 Jan 31;129(1):43-49. doi: 10.20452/pamw.4391. Epub 2018 Dec 13. Erratum in: Pol Arch Intern Med. 2019 Feb 28;129(2):145.

9.

Impact on confidence and practice: How the ADAPT online patient care skills program made a difference for pharmacists.

Farrell B, Archibald D, Pizzola L, Ward N, Cho A, Tsang C.

Res Social Adm Pharm. 2019 Oct;15(10):1251-1258. doi: 10.1016/j.sapharm.2018.11.001. Epub 2018 Nov 7.

PMID:
30448031
10.

Deprescribing recommendations: An essential consideration for clinical guideline developers.

Moriarty F, Pottie K, Dolovich L, McCarthy L, Rojas-Fernandez C, Farrell B.

Res Social Adm Pharm. 2019 Jun;15(6):806-810. doi: 10.1016/j.sapharm.2018.08.014. Epub 2018 Sep 18.

PMID:
30241877
11.

Deprescribing: Future directions for research.

Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B.

Res Social Adm Pharm. 2019 Jun;15(6):801-805. doi: 10.1016/j.sapharm.2018.08.013. Epub 2018 Sep 18.

PMID:
30241876
12.

Deprescribing guidelines: An international symposium on development, implementation, research and health professional education.

Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W.

Res Social Adm Pharm. 2019 Jun;15(6):780-789. doi: 10.1016/j.sapharm.2018.08.010. Epub 2018 Sep 18.

PMID:
30241875
13.

Implementing deprescribing guidelines into frontline practice: Barriers and facilitators.

Conklin J, Farrell B, Suleman S.

Res Social Adm Pharm. 2019 Jun;15(6):796-800. doi: 10.1016/j.sapharm.2018.08.012. Epub 2018 Sep 18.

PMID:
30241874
14.

Deprescribing: An educational imperative.

Raman-Wilms L, Farrell B, Sadowski C, Austin Z.

Res Social Adm Pharm. 2019 Jun;15(6):790-795. doi: 10.1016/j.sapharm.2018.08.011. Epub 2018 Aug 28.

PMID:
30241871
15.

Déprescription des agonistes des récepteurs des benzodiazépines: Lignes directrices de pratique clinique fondées sur les données probantes.

Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B.

Can Fam Physician. 2018 May;64(5):e209-e224. French.

PMID:
29760269
Free PMC Article
16.

Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.

Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B.

Can Fam Physician. 2018 May;64(5):339-351.

17.

Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie: Guide de pratique clinique fondé sur des données probantes.

Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A.

Can Fam Physician. 2018 Jan;64(1):e1-e12. Review. French.

PMID:
29358261
Free PMC Article
18.

Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.

Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A.

Can Fam Physician. 2018 Jan;64(1):17-27. Review.

19.

Proceedings of the Canadian Frailty Network Summit: Medication Optimization for Frail Older Canadians, Toronto, Monday April 24, 2017.

Muscedere J, Kim P, Aitken P, Gaucher M, Osborn R, Farrell B, Holroyd-Leduc J, Mallery L, Siu H, Downar J, Lee TC, McDonald E, Burry L.

Can Geriatr J. 2017 Dec 22;20(4):253-263. doi: 10.5770/cgj.20.293. eCollection 2017 Dec.

20.

Déprescription des antihyperglycémiants chez les personnes âgées: Guide de pratique clinique fondé sur les données probantes.

Farrell B, Black C, Thompson W, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Bouchard M, Welch V.

Can Fam Physician. 2017 Nov;63(11):e452-e465. French.

PMID:
29138168
Free PMC Article

Supplemental Content

Loading ...
Support Center